progerinin
AssetSmall molecule
Inhibitor of progerin-lamin A interaction and binder of progerin to promote its clearance
- Stage
- Phase 2
- Modality
- Small molecule
- Target
- LMNA
- Indications
- 2
- Trials
- 2
- Developers
- 1
Indications
2Progeria
Phase 2COMPLETEDNCT06775041clinicaltrials.gov7 Oct 2026
Werner syndrome
Phase 2RECRUITINGNCT05847179clinicaltrials.gov7 Oct 2026
- Targets and what it contains3
- Owner and partners1
- Trials2
- Evidence for its targets3
- Competitors12
- Aging relevance2
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 2 sources